Potential New Triple Negative Breast Cancer Biomarkers

Breast Cancer Pathology Histology Image Source NIH

Image Source: National Institutes of Health

Sally Church on Pharma Strategy Blog has written about recent research in triple-negative breast cancer (TNBC).

She discusses a published study from Vanderbilt that identified six different subtypes of the disease; each subtype being sensitive to different drug therapies.

As Sally points out these subtypes could be used as a potential biomarker for patient selection into an appropriate clinical trial – yet another step in the direction of personalized medicine.

You can read more about this insightful research on Pharma Strategy Blog.  Sally will be attending the San Antonio Breast Cancer Symposium (SABCS) later this year.

, , , , , , , , , , , , , , ,

error: Content is protected !!